Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer

Autorzy:

Edyta Cedrowska ,MarekPruszynski ,Weronika Gaweda ,Michał Zuk (RADFARM),
Paweł Krysinski, Frank Bruchertseifer, Alfred Morgenstern, Maria-Argyro Karageorgou, Penelope Bouziotis, Aleksander Bilewicz

Finansowanie:
This research was funded by the National Science Centre (NCN) grant number UMO-2016/21/B/ST4/02133—OPUS.

It also based on work from COST Action CA 17140 “CancerNanomedicine from the Bench to the Bedside” supported by COST(European Cooperation in Science and Technology).

The contributionof Michał Zuk was realized within Project No POWR.03.02.00-00-I009/17-00 (OperationalProject Knowledge Education Development 2014–2020 co-financed by the European Social Fund).

Rok wydania:
2020

Liczba tomów:
nd

Liczba stron:
18